Saturday 17 October 2026
Export PGNY’s income statement to Excel — free account
Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 5.30%, EPS grew 80.0% and free cash flow fell 12.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
26.86
0.60
−2.18%
Follow PGNY
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 77.42 | 68.04 | 92.70 | 56.38 | 28.75 | 37.22 |
Piotroski F-Score |
— | — | 4 | 5 | 5 | 6 | 7 | 6 | 8 |
Altman Z-Score |
— | — | 10.89 | 26.69 | 27.56 | 12.65 | 13.03 | 8.34 | 8.89 |
P/S ratio |
0.62 | 0.62 | 2.48 | 10.54 | 8.96 | 3.58 | 3.25 | 1.35 | 1.71 |
P/FCF ratio |
16.55 | 16.55 | 0.00 | 103.33 | 187.66 | 36.55 | 19.09 | 9.09 | 11.47 |
Altman Z″-Score (non-manufacturers) |
(12.83) | (10.46) | 5.49 | 4.27 | 6.00 | 6.15 | 7.74 | 7.20 | 7.14 |
Beneish M-Score |
— | (2.53) | (1.70) | (1.33) | (1.22) | (2.38) | (3.23) | (3.33) | (3.45) |
P/Operating CF |
20.26 | 20.26 | (103.69) | 555.88 | 508.96 | 54.74 | 93.89 | 30.25 | 40.58 |
P/B ratio |
0.00 | 0.00 | 4.98 | 21.77 | 17.82 | 7.48 | 6.39 | 3.74 | 4.26 |
Price to Tangible BV |
0.00 | 0.00 | 5.69 | 23.62 | 18.75 | 7.73 | 6.53 | 3.89 | 4.49 |
EV/Sales |
0.60 | 0.60 | 2.15 | 10.23 | 8.73 | 3.35 | 2.91 | 1.16 | 1.47 |
EV/EBITDA |
11.60 | 11.60 | 41.79 | 344.18 | 129.96 | 105.67 | 49.16 | 19.18 | 20.99 |
EV/Operating CF |
14.43 | 14.43 | (321.74) | 97.49 | 167.91 | 32.78 | 16.79 | 7.56 | 9.01 |
EV/FCF |
16.15 | 16.15 | (109.92) | 100.36 | 182.86 | 34.16 | 17.12 | 7.80 | 9.88 |
Quick Ratio |
0.90 | 0.78 | 3.52 | 2.38 | 2.57 | 2.69 | 3.30 | 2.75 | 2.62 |
Current Ratio |
0.94 | 0.81 | 3.66 | 2.45 | 2.62 | 2.72 | 3.44 | 2.80 | 2.73 |
Net Debt/EBITDA |
(0.05) | (0.08) | (6.81) | (10.66) | (3.55) | (7.59) | (5.76) | (3.23) | (3.44) |
Debt/Assets |
14.84% | 0.61% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.05) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.27 | 2.76 | 2.40 | 1.71 | 1.64 | 1.75 | 1.68 | 1.71 | 1.91 |
Operating CF/Net income |
0.70 | 3.44 | 0.18 | 0.78 | 0.40 | 2.65 | 3.04 | 3.30 | 3.59 |
Capex/Depreciation |
(0.35) | (0.30) | (1.39) | (0.54) | (1.64) | (2.02) | (1.60) | (1.70) | (3.72) |
Interest Coverage |
(14.87) | (6.95) | 166.84 | 68.99 | 70.15 | 28.67 | — | — | — |
| 13.98% | (0.69%) | (89.47%) | 33.04% | 31.41% | 9.66% | 13.34% | 11.14% | 12.48% | |
| (35.31%) | 1.73% | (8.94%) | 22.98% | 21.49% | 6.74% | 9.55% | 7.97% | 8.67% | |
ROIC |
0.00% | 0.00% | 17.85% | 9.05% | 15.27% | 7.77% | 21.31% | 21.72% | 25.88% |
Return on Tangible Assets |
3,341.94% | (13.52%) | (8.62%) | 40.11% | 39.92% | 10.74% | 13.35% | 17.17% | 15.43% |
Average Days of Receivables |
85.44 | 80.77 | 74.78 | 80.08 | 98.10 | 111.35 | 81.10 | 73.59 | 62.39 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
37.88% | 21.71% | 15.60% | 17.89% | 15.94% | 18.30% | 16.22% | 15.93% | 17.01% |
Intangible Assets out of Total Assets |
0.49 | 0.38 | 0.09 | 0.05 | 0.03 | 0.02 | 0.02 | 0.03 | 0.04 |
Share Based Compensation of Revenue |
3.21% | 2.84% | 2.20% | 3.72% | 6.73% | 12.80% | 11.26% | 10.98% | 10.23% |
Graham Net Nets |
(0.93) | (0.93) | 0.17 | 0.03 | 0.03 | 0.10 | 0.12 | 0.18 | 0.15 |
Graham Number |
0.00 | 0.00 | 0.00 | 4.90 | 6.86 | 5.51 | 9.30 | 7.89 | 9.67 |
Earnings Yield |
(3.26%) | (3.26%) | (1.41%) | 1.29% | 1.47% | 1.08% | 1.77% | 3.48% | 2.69% |
Free Cash Flow Yield |
6.04% | 6.04% | (0.79%) | 0.97% | 0.53% | 2.74% | 5.24% | 11.01% | 8.72% |
Revenue per Share |
8.56 | 19.03 | 11.08 | 4.02 | 5.62 | 8.54 | 11.46 | 12.76 | 15.05 |
Operating CF per Share |
(1.67) | 0.41 | (0.07) | 0.42 | 0.29 | 0.87 | 1.99 | 1.96 | 2.45 |
Capex per Share |
(0.11) | (0.10) | (0.14) | (0.01) | (0.02) | (0.04) | (0.04) | (0.06) | (0.21) |
Free Cash Flow per Share |
(1.78) | 0.31 | (0.22) | 0.41 | 0.27 | 0.84 | 1.95 | 1.90 | 2.24 |
Cash per Share |
0.83 | 0.02 | 3.88 | 1.28 | 1.34 | 2.05 | 3.91 | 2.49 | 3.62 |
Shareholders Equity per Share |
(17.19) | (17.17) | 5.51 | 1.95 | 2.83 | 4.09 | 5.82 | 4.61 | 6.02 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(17.19) | (17.17) | 5.51 | 1.95 | 2.83 | 4.09 | 5.82 | 4.61 | 6.02 |
Free Cash Flow |
(10.09) | 1.69 | (4.49) | 35.17 | 23.91 | 77.15 | 185.17 | 173.70 | 191.78 |
Working Capital |
(1.00) | (5.66) | 96.28 | 112.44 | 159.72 | 274.32 | 454.46 | 304.09 | 349.38 |
Capital Expenditures |
(0.61) | (0.58) | (2.96) | (1.04) | (2.13) | (3.24) | (3.64) | (5.40) | (18.41) |
Net Current Asset Value |
(115.81) | (111.90) | 96.28 | 103.24 | 152.30 | 267.84 | 437.22 | 287.68 | 325.38 |
EV/EBIT |
14.62 | 14.62 | 51.00 | 422.77 | 135.18 | 112.92 | 50.97 | 20.09 | 22.21 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Price to Operating Income |
14.99 | 14.99 | 58.82 | 435.29 | 138.73 | 120.83 | 56.86 | 23.39 | 25.79 |
| Other line items | |||||||||
Depreciation/Fixed assets |
2.95 | 2.52 | 0.69 | 0.56 | 0.26 | 0.19 | 0.22 | 0.26 | 0.17 |
Cash ROIC |
11.49% | (1.79%) | (2.31%) | 12.73% | 6.44% | 13.62% | 20.03% | 26.72% | 23.21% |
Accounts Receivable Turnover |
2.80 | 6.08 | 6.53 | 5.62 | 4.76 | 4.20 | 4.52 | 4.89 | 5.66 |
Accounts Payable Turnover |
3.98 | 8.30 | 10.53 | 8.74 | 7.41 | 7.26 | 7.24 | 8.29 | 8.98 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
45.47 | 66.14 | 38.42 | 57.80 | 57.69 | 64.38 | 53.87 | 37.98 | 46.01 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
17.35 | 17.35 | 35.19 | 61.36 | 105.11 | 187.31 | 240.97 | 238.60 | 227.81 |
Average Payables |
10.35 | 10.35 | 17.48 | 31.45 | 52.46 | 85.34 | 117.36 | 110.26 | 109.58 |
Average Assets |
38.14 | 38.14 | 95.88 | 202.18 | 306.00 | 450.53 | 649.80 | 681.86 | 674.77 |
Average Common Equity |
(96.37) | (96.37) | 9.58 | 140.61 | 209.38 | 314.40 | 465.20 | 487.75 | 469.05 |
Columns are period end dates